Newstral
Article
Ppacbiztimes.com on 2016-01-08 01:21
Settlement ends Amgen drug kickback saga
Related news
- PAmgen drug Kyprolis gets another FDA approvalpacbiztimes.com
- PAmgen Acquires German Drugpacbiztimes.com
- Indiana Part of Amgen Settlementinsideindianabusiness.com
- Amgen latest pharma to pay millions to settle drug kickback claimsbizjournals.com
- PAmgen asks FDA to approve biosimilar drugpacbiztimes.com
- PFDA OKs Amgen skin cancer drug Imlygicpacbiztimes.com
- PEuropean regulators approve Amgen cancer drug Kyprolispacbiztimes.com
- PAmgen bone density drug shows positive resultspacbiztimes.com
- FDA approves Amgen heart failure drug CorlanorLA Times
- PAmgen seeks European OK of biosimilar drug, partners with Merck on studiespacbiztimes.com
- Drug makers Astellas Pharma and Amgen to pay US$125 million in US charity kickback probe, as both deny wrongdoingSouth China Morning Post
- Another Biosimilar Litigation Settlement: Amgen v. Tanvex (Filgrastim)jdsupra.com
- PStudy results positive for drug Amgen developing to treat osteoporosispacbiztimes.com
- Settlement reached in kickback lawsuitjournalrecord.com
- PAmgen alum speeds toward OK for chin drugpacbiztimes.com
- PAmgen gets FDA approval for migraine drug Aimovigpacbiztimes.com
- PFDA gives full approval to Amgen leukemia drug Blincytopacbiztimes.com
- FDA panel backs Amgen cholesterol drug for some patientsabc3340.com
- PAmgen clinical trial shows promising results for migraine drug Aimovigpacbiztimes.com
- PAmgen shares drop as Novartis launches cheaper drugpacbiztimes.com